rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2003-12-5
|
pubmed:abstractText |
High serum levels of neuron-specific enolase (NSE) and S-100B protein are known to be associated with ischemic brain injury and poor outcome after cardiac arrest. Therapeutic hypothermia has been shown to improve neurological outcome after cardiac arrest. The aim of this study was to evaluate the effect of therapeutic hypothermia on levels of serum NSE and S-100B protein, their time course, and their prognostic value in predicting unfavorable outcome after out-of-hospital cardiac arrest.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1524-4628
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2881-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14631087-Adolescent,
pubmed-meshheading:14631087-Adult,
pubmed-meshheading:14631087-Aged,
pubmed-meshheading:14631087-Area Under Curve,
pubmed-meshheading:14631087-Biological Markers,
pubmed-meshheading:14631087-Cardiopulmonary Resuscitation,
pubmed-meshheading:14631087-Female,
pubmed-meshheading:14631087-Finland,
pubmed-meshheading:14631087-Heart Arrest,
pubmed-meshheading:14631087-Humans,
pubmed-meshheading:14631087-Hypothermia, Induced,
pubmed-meshheading:14631087-Male,
pubmed-meshheading:14631087-Middle Aged,
pubmed-meshheading:14631087-Nerve Growth Factors,
pubmed-meshheading:14631087-Phosphopyruvate Hydratase,
pubmed-meshheading:14631087-Predictive Value of Tests,
pubmed-meshheading:14631087-Prognosis,
pubmed-meshheading:14631087-ROC Curve,
pubmed-meshheading:14631087-S100 Proteins,
pubmed-meshheading:14631087-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.
|
pubmed:affiliation |
Department of Neurology, Helsinki University Central Hospital, Finland. marjaana.tiainen@hus.fi
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|